PRESS RELEASE published on 02/10/2026 at 15:09, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. reports a 5.08% stake in JTC plc as of 09-Feb-2026. Details include 8,754,627 shares held at 1p ordinary stock Shares The Vanguard Group Stake 1p Ordinary JTC Plc
PRESS RELEASE published on 02/10/2026 at 15:09, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.82% ownership in Avadel Pharmaceuticals plc. Form 8.3 filed with Irish Takeover Panel on 10-Feb-2026 Form 8.3 Irish Takeover Panel Vanguard Group Ownership Disclosure Avadel Pharmaceuticals
PRESS RELEASE published on 02/10/2026 at 15:08, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.03% stake in Beazley plc as of 9 February 2026. Purchase transactions made at 12.40 GBP and 12.45 GBP per unit Vanguard Group Stake Purchase Transactions GBP Beazley Plc
PRESS RELEASE published on 02/10/2026 at 15:07, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.60% stake in Spire Healthcare Group plc. Form 8.3 filing made on 10-Feb-2026 Form 8.3 The Vanguard Group Financial Filing Stake Disclosure Spire Healthcare Group Plc
PRESS RELEASE published on 02/10/2026 at 15:06, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% interest in Just Group plc in accordance with Rule 8.3 of the Takeover Code Disclosure The Vanguard Group Rule 8.3 Takeover Code Just Group Plc
PRESS RELEASE published on 02/10/2026 at 15:06, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses 5.25% stake in Picton Property Income Limited as per Form 8.3, dated 10-Feb-2026 Securities Form 8.3 Vanguard Group Picton Property Income Stake Disclosure
PRESS RELEASE published on 02/10/2026 at 15:05, 11 days 19 hours ago HUMAIN Launches HUMAIN Sport Following Acquisition of Controlling Stake in ai.io HUMAIN launches HUMAIN Sport after acquiring controlling stake in ai.io, advancing AI-driven sports technology globally through strategic partnership Acquisition AI-driven Sport Humain Ai.io
PRESS RELEASE published on 02/10/2026 at 15:05, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses a 4.72% stake in NCC Group plc, as of 09/02/2026. Detailed Form 8.3 submission under Rule 8.3 of the Takeover Code Form 8.3 The Vanguard Group Rule 8.3 Takeover Code NCC Group Plc
PRESS RELEASE published on 02/10/2026 at 15:04, 11 days 19 hours ago Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The The Vanguard Group, Inc. discloses 5.44% stake in British Land Company plc. No other party disclosures made Vanguard Group Financial Disclosure Stake Disclosure Stock Holdings British Land Company
PRESS RELEASE published on 02/10/2026 at 15:00, 11 days 19 hours ago Press Release: Sanofi completes the acquisition of Dynavax Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities Acquisition Sanofi Vaccine Immunization Dynavax
Published on 02/21/2026 at 00:45, 1 day 10 hours ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 10 hours ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 1 day 11 hours ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 12 hours ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/22/2026 at 10:09, 37 minutes ago Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 22 hours 47 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 22 hours 47 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 16 hours ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 19:29, 1 day 15 hours ago SFPI GROUP: bilan du contrat de liquidité S2 S025
